CY1113739T1 - Βακτηριδιο γαλακτικου οξεος με αυξημενη ανοχη σε οξυ - Google Patents

Βακτηριδιο γαλακτικου οξεος με αυξημενη ανοχη σε οξυ

Info

Publication number
CY1113739T1
CY1113739T1 CY20121101207T CY121101207T CY1113739T1 CY 1113739 T1 CY1113739 T1 CY 1113739T1 CY 20121101207 T CY20121101207 T CY 20121101207T CY 121101207 T CY121101207 T CY 121101207T CY 1113739 T1 CY1113739 T1 CY 1113739T1
Authority
CY
Cyprus
Prior art keywords
increased
tolerance
lactic acid
acid
acid bacteria
Prior art date
Application number
CY20121101207T
Other languages
Greek (el)
English (en)
Inventor
Eamonn Connolly
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of CY1113739T1 publication Critical patent/CY1113739T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/08Reducing the nucleic acid content
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/173Reuteri
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CY20121101207T 2006-06-05 2012-12-10 Βακτηριδιο γαλακτικου οξεος με αυξημενη ανοχη σε οξυ CY1113739T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/446,648 US8603460B2 (en) 2006-06-05 2006-06-05 Method of making a Lactobacillus reuteri with increased acid tolerance
EP07748543A EP2040723B1 (en) 2006-06-05 2007-05-30 Lactic acid bacterium with increased acid tolerance

Publications (1)

Publication Number Publication Date
CY1113739T1 true CY1113739T1 (el) 2016-06-22

Family

ID=38790469

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121101207T CY1113739T1 (el) 2006-06-05 2012-12-10 Βακτηριδιο γαλακτικου οξεος με αυξημενη ανοχη σε οξυ

Country Status (12)

Country Link
US (1) US8603460B2 (enExample)
EP (2) EP2548945A3 (enExample)
JP (1) JP2009539372A (enExample)
KR (1) KR20090014264A (enExample)
CN (1) CN101432006B (enExample)
CY (1) CY1113739T1 (enExample)
DK (1) DK2040723T3 (enExample)
ES (1) ES2398590T3 (enExample)
PL (1) PL2040723T3 (enExample)
PT (1) PT2040723E (enExample)
SI (1) SI2040723T1 (enExample)
WO (1) WO2007142597A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
CN101993152B (zh) * 2010-09-21 2012-06-20 浙江大学 一种增强油脂降解菌降解能力的激活剂及其用途和使用方法
US20160279180A1 (en) * 2013-08-23 2016-09-29 Consejo Superior de Investigaciones Científicas ( CSIC) Probiotic Strain of Lactobacillus Reuteri Exhibiting Anti-Helicobacter Activity, a Probiotic or Biotherapeutic Product Comprising Said Strain, and the Use Thereof
BR112022008559A2 (pt) * 2019-11-08 2022-08-09 Biogaia Ab Bactéria produtora de serotonina

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508738A (en) * 1982-03-17 1985-04-02 Microlife Technics, Inc. Non-sucrose fermenting Pedioccus pentosaceus
US4518696A (en) 1983-01-11 1985-05-21 Chr. Hansen's Laboratory, Inc. Stabilized liquid bacterial suspension for oral administration to animals
US5413960A (en) 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
US5080897A (en) * 1987-05-08 1992-01-14 Ecogen Inc. Novel bacillus thuringiensis strains, and related insecticidal compositions
US5458875A (en) 1990-06-15 1995-10-17 Biogaia Ab In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry
US5534253A (en) 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
ATE239486T1 (de) 1995-12-21 2003-05-15 Biogaia Ab Verwendung von lactobacillus reuteri zur hemmung der kryptosporidiosis in säugetieren
US5837238A (en) 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
US5800813A (en) 1996-11-12 1998-09-01 Biogaia Biologics Ab Treatment of cryptosporidium infections
KR19990024297A (ko) 1997-08-07 1999-04-06 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US6100388A (en) 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US7045338B2 (en) * 2002-03-08 2006-05-16 E. I. Du Pont De Nemours And Company Temperature sensitive mutant derivatives of the broad host range plasmid pBHR1
GB0205647D0 (en) 2002-03-11 2002-04-24 Danisco Cultor Niebull Gmbh Method of improving food fermentation procedures
US7105336B2 (en) 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
US20040208863A1 (en) 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria

Also Published As

Publication number Publication date
EP2040723A4 (en) 2010-06-16
CN101432006A (zh) 2009-05-13
DK2040723T3 (da) 2013-03-25
ES2398590T3 (es) 2013-03-20
WO2007142597A1 (en) 2007-12-13
US20070280914A1 (en) 2007-12-06
EP2548945A3 (en) 2013-04-24
EP2548945A2 (en) 2013-01-23
EP2040723A1 (en) 2009-04-01
PT2040723E (pt) 2013-01-29
KR20090014264A (ko) 2009-02-09
SI2040723T1 (sl) 2013-03-29
US8603460B2 (en) 2013-12-10
HK1132659A1 (en) 2010-03-05
CN101432006B (zh) 2012-08-22
JP2009539372A (ja) 2009-11-19
EP2040723B1 (en) 2012-11-28
PL2040723T3 (pl) 2013-03-29

Similar Documents

Publication Publication Date Title
CY1122285T1 (el) Ψημενα προϊοντα
MY169996A (en) Biocatalytic oxidation process with alkl gene product
CY1120174T1 (el) Συνθεσεις και μεθοδοι για την αναστολη εκφρασης τρανσθυρετινης
CY1118875T1 (el) Αντιδοτα αντιπηκτικων
CY1118349T1 (el) Παραγοντες συνδεσης me cd19 και χρησεις αυτων
GB0906322D0 (en) Immobilized product tolerant microorganisms
BRPI0822633A2 (pt) Desinfetante, e, método de esterilização.
BRPI0817062A2 (pt) Composições emolientes e de poliamida, produtos produzidos e métodos de produção e utilização de tais composições e produtos.
CY1115595T1 (el) Αλατα ρασιγιλινης και φαρμακευτικη παρασκευη αυτων
EA201101582A1 (ru) Интеллектуальная упаковка для выявления микроорганизмов
WO2011012316A3 (de) Rna mit einer kombination aus unmodifizierten und modifizierten nucleotiden zur proteinexpression
DE112007001930A5 (de) Titandioxid enthaltendes Komposit
BR112014030202A2 (pt) microorganismos e métodos para a produção de 4-hidroxibutirato 1,4-butanodiol e compostos relacionados
EA200870290A1 (ru) Молочно-кислые бактерии, обеспечивающие улучшенную текстуру ферментированных молочных продуктов
UA107822C2 (xx) Визначені триазолопіридини та триазолопіразини, їх композиції та їх застосування
BRPI1014056A2 (pt) micro-organismos de corynebacterium com maior produtividade de ácido 5'-inosínico e método para produzir ácidos nucleicos com eles.
EP2313928A4 (en) GEOMETRICAL DIODE, APPLICATIONS AND METHODS
MX2012008738A (es) Microorganismos y metodos para la biosintesis de p-toluato y tereftalato.
CY1118710T1 (el) Συνθεσεις για την θεραπεια της πολλαπλης σκληρυνσης
RU2011135537A (ru) Штамм enterococcus hirae, используемый при производстве кисломолочных продуктов
IN2012DN01604A (enExample)
BR112017011850A2 (pt) métodos e reagentes para detectar neisseria gonorrhoeae e seus determinantes de resistência antimicrobiana
CY1113739T1 (el) Βακτηριδιο γαλακτικου οξεος με αυξημενη ανοχη σε οξυ
CY1113213T1 (el) Παρασκευη χαρτιου μεταφορας για την εκτυπωση με εγχυση μελανης
CY1113641T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει aleglitazar